0
Clinical Investigations: PULMONARY HYPERTENSION |

Hemodynamic Effects of Aerosolized Iloprost in Pulmonary Hypertension at Rest and During Exercise*

Friedrich C. Blumberg, MD; Günter A. J. Riegger, MD; Michael Pfeifer, MD
Author and Funding Information

*From the Department of Internal Medicine II, University of Regensburg, Regensburg, Germany.

Correspondence to: Friedrich C. Blumberg, MD, Department of Internal Medicine II, University of Regensburg, 93042 Regensburg, Germany; e-mail: friedrich.blumberg@klinik.uni-regensburg.de



Chest. 2002;121(5):1566-1571. doi:10.1378/chest.121.5.1566
Text Size: A A A
Published online

Study objectives: Aerosolized iloprost, a stable prostacyclin analog, improves functional capacity even in patients with pulmonary hypertension who did not show a vigorous hemodynamic response after iloprost inhalation at rest. We therefore speculated that aerosolized iloprost elicits more beneficial effects on pulmonary hemodynamics during exercise than at rest.

Design and setting: A prospective, open, uncontrolled study at a university hospital.

Patients: Sixteen patients with primary or secondary pulmonary hypertension.

Interventions: Right-heart catheterization at rest and during exercise before and after the inhalation iloprost, 14 to 28 μg.

Results: Before iloprost treatment, exercise increased mean (± SD) pulmonary artery pressure (PAPm) from 45 ± 8 to 70 ± 13 mm Hg, cardiac output from 3.7 ± 1.0 to 5.8 ± 2.4 L/min, and pulmonary vascular resistance (PVR) from 904 ± 322 to 1,013 ± 432 dyne·s·cm−5 (each p < 0.05). After recovery, iloprost reduced PAPm from 44 ± 8 to 41 ± 6 mm Hg, increased cardiac output from 3.7 ± 1.0 to 4.9 ± 1.4 L/min, and lowered PVR from 902 ± 350 to 636 ± 248 dyne·s·cm−5 (each p < 0.05). During exercise after iloprost, PAPm increased to 57 ± 8 mm Hg, cardiac output to 7.0 ± 3.0 L/min, and PVR to 673 ± 279 dyne·s·cm−5 (each p < 0.05 vs first exercise test). Systemic BP was not altered significantly by iloprost treatment during exercise.

Conclusions: Aerosolized iloprost treatment exerts more favorable effects on pulmonary hemodynamics during exercise than at rest. These findings explain the functional improvement observed in patients with pulmonary hypertension who show only a moderate pulmonary vasodilatory response during iloprost inhalation at rest. Whether these beneficial effects have prognostic significance needs to be elucidated by further study.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543